Polihexanide: A safe and highly effective biocide

Skin Pharmacology and Physiology

Volumn 23, Issue SUPPL. 1, 2010, Pages 7-16

  Kaehn, K ^a  

^a K2 Hygiene Dienstleistungen ^*  (Germany)

Author keywords

Antiseptic; Biocide; Polihexanide; Polihexanide, chemical characteristics; Wounds

Indexed keywords

BAQUACIL; BENZALKONIUM CHLORIDE; BETAINE; CHLORHEXIDINE; COSMOCIL CQ; OCTENIDINE; POLY(HEXAMETHYLENEBIGUANIDE); POLYPEPTIDE ANTIBIOTIC AGENT; POVIDONE IODINE; PRONTOLIND; PRONTORAL; PRONTOSAN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BIODEGRADATION; BIOFILM; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG ELIMINATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TRANSFORMATION; HUMAN; LD 50; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA; BIGUANIDES; BIOFILMS; DISINFECTANTS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; PSEUDOMONAS AERUGINOSA; SKIN; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

EID: 77956537447     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318237     Document Type: Review

References (66)

1. Davies GE, Francis J, Martin AR, Rose FL, Swain G: l:6-Di-4'- chlorophenyldigua-nidohexane ('hibitane'); laboratory investigation of a new antibacterial agent of a high potency. Br J Pharmacol Chemother 1954;9: 192-196.
2. Willenegger H: Lokale Antiseptika in der Chirurgie-eine Wiedergeburt? Un-fallchirurg 1994;20:94-110.
3. Willenegger H: Klinische Erfahrungen mit einem neuen Antiinfektivum. Hyg Med 1994;19:227-233.
4. Kaehn K, Eberlein T: Polyhexanide (PHMB) and betaine in wound care management. EWMA J 2008;8:13-17.
5. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S: Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007;20:292-296.
6. Gerli S, Rossetti D, Di Renzo GC: A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study. Eur Rev Med Pharmacol Sci 2003;7:127-130.
7. Hansmann F, Kramer A, Ohgke H, Strobel H, Geerling G: Polyhexamethylbiguanid (PHMB) zur praoperativen Antisepsis bei Cataract Operation. Ophthalmologe 2004; 101:377-383.
8. Kramer A, Daeschlein G, Kammerlander G, Andriessen A, Aspock C, Bergemann R, Eberlein T, Gerngross H, Gortz G, Heeg P, Junger M, Koch S, KonigB, Laun R Peter RU, Roth B, Ruef C, Sellmer W, Wewalka G Eisenbeiss W: Konsensusempfehlung zur Auswahl von Wirkstoffen fur die Wundan-tiseptik. Hyg Med 2004;5:147-157.
9. Ikeda T, Tazuke S, Watanabe M: Interaction of biologically active molecules with phospholipid membranes. Fluorescence depolar-isation studies on the effect of polymeric bio-cide bearing biguanides in the main chain. Biochim Biophys Acta 1983;735:380-386.
10. Ikeda T, Ledwith A, Bamford CH, Hann RA: Interaction of polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta 1984;769:57-66.
11. Ikeda T, Tazuke S, Bamford CH: Interaction of membrane active biguanides with negatively charged species. A model of their interaction with target sites in microbial membranes. J Chem Res 1985;6:180-181.
12. Ikeda T, Tazuke S, Bamford CH, Ledwith A: Spectroscopic studies on the interaction of polymeric in-chain biguanide biocide with phospholipid membranes as probed by 8-anilinonaphthalene-l-sulphonate. Bull Chem Soc Jpn 1985;58:705-709.
13. Kramer A: Stellenwert der Infektionspro-phylaxe und-therapie mit lokalen Antiin-fektiva; in Kramer A, Wendt M,. Werner HP (eds): Moglichkeiten und Perspektiven der klinischen Antiseptik. Wiesbaden, mhp, 1995, pp 15-25.
14. Frieling H, Grundling M, Lauer KS, Wendt M, Hackenberg T, Lehmann C, Pavlovic D: Intraperitoneal instillation of polihexanide produces hypotension and vasodilation: in vivo and in vitro study in rats. Int J Colorectal Dis 2006;21:373-383.
15. Berg A, Assadian O, Rudolph P, Mundkows-ki RG, Janda J, Kramer A: Intolerability to Lavasept® peritoneal lavage in experimentally induced peritonitis in the guinea pig. Hyg Med 2008;33:189-193.
16. Kramer A, Roth B, Muller G, Rudolph P, Klocker N: Influence of the antiseptic agents polihexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 2004; 17:141-146.
17. Korber A, Dissemond J: Polyhexanid schutzt vor Kollagendegradierung: Erste Resultate einer in vitro Untersuchung zu Koll-P-10. ZfW 2007;4:213-216.
18. Langer S, Sedigh Salakdeh M, Goertz O, Steinau HU, Steinstraesser L, Homann HH: The impact of topical antiseptics on skin microcirculation. Eur J Med Res 2004;9:449-454.
19. Rose FL, Swain G: Bisdiguanides having antibacterial activity. J Chem Soc 1956;850: 4422-4425.
20. Bratt H, Hathway DE: Characterization of the urinary polymer-related material from rats given poly[biguanide-l,5-diylhexa-methylene hydrochlorid]. Macromol Chem Phys 1976;177:2591-2605.
21. O'Malley LP, Hassan KZ, Brittan H, Johnson N, Collins AN: Characterization of the biocide polyhexamethylene biguanide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Appl Polym Sci Symp 2006;102:4928-4936.
22. Kurzer F, Pitchfork ED: Biguanides. Berlin, Springer, 1968.
23. Davies A, Bentley M, Field BS: Comparison of the action of vantocil, cetrimide and chlorhexidine on Escherichia coli and its spheroplasts and the protoplasts of gram-positive bacteria. J Appl Bacterid 1968;31: 448-461.
24. Kramer A, Roth B: Polihexanid; in Kramer A, Assadian O (eds): Wallhaussers Praxis der Sterilisation, Desinfektion, Antiseptik und Konservierung. Qualitatssicherung der Hygiene in Industrie, Pharmazie und Medizin. Stuttgart, Thieme, 2008, pp 789-793.
25. Broxton P, Woodcock PM, Heatley F, Gilbert P: Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J Appl Bacterid 1984; 57: 115-124. (Pubitemid 14037967)
26. Gilbert P, Pemberton D, Wilkinson DE: Barrier properties of gram-negative cell envelope towards high molecular weight polyhexamethylene biguanides. J Appl Bacterid 1990;69:585-592.
27. Gilbert P, Pemberton D, Wilkinson DE: Synergism within polyhexamethylene bigua-nide biocide formulations. J Appl Bacterid 1990;69:593-598.
28. Yasuda K, Ohmizo C, Katsu T: Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes. J Microbiol Methods 2003; 54:111-115.
29. Allen MJ, White GF, Morby AP: The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 2006;152:989-1000.
30. Glukhov E, Stark M, Burrows LL, Deber CM: Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem 2005;280:33960-33967.
31. Singer SJ, Nicolson GL: The fluid mosaic model of the structure of cell membranes. Science 1972;175:720-731.
32. Zhu S: Evidence for myxobacterial origin of eukaryotic defensins. Immunogenetics 2007;59:949-954.
33. Smith JG, Nemerow GR: Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe 2008;3:11-19.
34. Taylor K, Clarke DJ, McCullough B, Chin W, Seo E, Yang D, Oppenheim J, Uhrin D, Go-van JR, Campopiano DJ, MacMillan D, Bar-ran P, Dorin JR: Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J Biol Chem 2008;283:6631-6639.
35. Krishnakumari V, Nagaraj R: Interaction of antibacterial peptides spanning the carboxy-terminal region of human beta-defensins 1-3 with phospholipids at the air-water interface and inner membrane of E. coli. Peptides 2008;29:7-14.
36. Vylkova S, Sun JN, Edgerton M: The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides. Purinergic Signal 2007; 3:91-97.
37. Sugiarto H, Yu PL: Mechanisms of action of ostrich beta-defensins against Escherichia coli. FEMS Microbiol Lett 2007;270:195-200.
38. Morgera F, Antcheva N, Pacor S, Quaroni L, Berti F, Vaccari L, Tossi A: Structuring and interactions of human beta-defensins 2 and 3 with model membranes. J Pept Sci 2008; 14: 518-523.
39. Donlan RM: Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8:881-890.
40. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA: Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006;1:1-2.
41. Bjarnsholt T, Kirketerp-Moller K, Jensen P0, Madsen KG, Phipps R Krogfelt K, Hoiby N, Givskov M: Why chronic wounds will not heal: a novel hypothesis. Wound Repair Re-gen 2008;16:2-10.
42. Seipp HM, Hofmann S, Hack A, Skowronsky A, Hauri A: Efficacy of various wound irrigation solutions against biofilms. ZfW 2005;4: 160-164.
43. Blackburn RS, Harvey A, Kettle LL, Payne JD, Russell SJ: Sorption of polyhexamethylene biguanide) on cellulose: mechanism of binding and molecular recognition. Lang-muir 2006;22:5636-5644.
44. Kusnetsov JM, Tulkki AI, Ahonen HE, Mar-tikainen PJ: Efficacy of tree prevention strategies against Legionella in cooling water systems. J Appl Microbiol 1997;82:763-768.
45. Perez R, Davis SC, Kaehn K: Wirkung ver-schiedener Wundspullosungen auf MRSA-Biofilme in Wunden im Tiermodel. Wund-Management 2010,4:44-48.
46. Elsztein C, de Menezes JAS, de Morais MA Jr: Polyhexamethyl biguanide can eliminate contaminant yeasts from fuel-ethanol fermentation process. J Ind Microbiol Biotech-nol 2008;35:967-973.
47. Messick CR Pendland SL, Moshirfar M, Fis-cella RG, Losnedahl KJ, Schriever CA, Schreckenberger PC: In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis. J Antimicrob Chemother 1999; 44:297-298.
48. Liu N, Khong D, Chung SK, Hwang DG: In-vitro susceptibility of ocular bacterial and fungal pathogens to polyhexamethylene biguanide. Invest Ophthamol Vis Sci 1996;37: 4058.
49. Larkin DFP, Kilvington S, Dart JKG: Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. J Ophthalmol 1992;99:185-191.
50. Donoso R, Mura JJ, Lopez M: Acanthamoeba keratitis treated with propamidine and polyhexamethylene biguanide (PHMB). Rev Med Chil 2002;130:396-401.
51. Narasimhan S, Madhavan HN, Therese LK: Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 2002; 21:203-205.
52. Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B: Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Phar-macother 2005;59:438-445.
53. Andriessen AE, Eberlein T: Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds 2008;20:171-175.
54. Moller A, Kaehn K, Nolte A: Erfahrun-gen mit dem Einsatz polyhexanidhaltiger Wundprodukte bei der Versorgung chroni-scher Wunden-Ergebnisse einer system-atischen retrospektiven Untersuchung an 953 Patienten. WundManagement 2008; 3: 112-117.
55. Cazzaniga A, Serralta V, Davis S, Orr R, Ea-glestein W, Mertz PM: The effect of an antimicrobial gauze dressing impregnated with 0.2 percent polyhexamethylene biguanides as a barrier to prevent Pseudomonas aeruginosa wound invasion. Wounds 2002;14:169-176.
56. United States Environmental Protection Agency: Reregistration eligibility decision of PHMB. EPA739-R-05-1003, September 2005.
57. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten FA: The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque re-growth. J Clin Periodontol 2002; 98:392-399.
58. Brecx M, Decker EM, Freitag HP, Maier G, von Ohle C: The effect of polihexanide on dental biofilm formation in vivo. J Dent Res 2008;87:0528.
59. 14C] polyhexamethylene hydrochloridbi-guanide. Bull Environ Contam Toxicol 1996; 36:121-128.
60. Zollner H, Kramer A, Youssef P, Youssef U, Adrian V: Preliminary investigations on the biodegradability of selected microbicidal agents. Hyg Med 1995;20:401-407.
61. O'Malley LP, Collins AN, White GF: Biodegradability of end-groups of the biocide polyhexamethylene biguanide (PHMB) assessed using model compounds. J Ind Microbiol Biotechnol 2006;33:677-684.
62. O'Malley LP, Shaw CH, Collins AN: Microbial degradation of the biocide polyhexamethylene biguanide: isolation and characterization of enrichment consortia and determination of degradation by measurement of stable isotope incorporation into DNA. J Appl Microbiol 2007;103:1158-1169.
63. Kawai F: Sphingomonads involved in the biodegradation of xenobiotic compounds. J Ind Microbiol Biotechnol 1999;23:400-407.
64. Hiraishi T, Kajiyama M, Yamoto I, Doi Y Enzymatic hydrolysis of alpha-and beta-oligo(L-aspartic acid) by poly(aspartic acid) hydrolases-1 and 2 from Sphingomonas sp. KT-1. Macromol Biosci 2004;4:330-339.
65. Vacca DJ, Bleam WF, Hickey WJ: Isolation of soil bacteria adapted to degrade humic acid-sorbed phenanthrene. Appl Environ Microbiol 2005;71:3797-3805.
66. Mishima Y, Momma K, Hashimoto W, Mi-kami B, Murata K: Super-channel in bacteria: function and structure of the macro-molecule import system mediated by a pit-dependent ABC transporter. FEMS Microbiol Lett 2001;204:215-221. (Pubitemid 33145257)